These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 798531)

  • 21. Born with a habit. Infants of drug-addicted mothers.
    Rothstein P; Gould JB
    Pediatr Clin North Am; 1974 May; 21(2):307-21. PubMed ID: 4837169
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants.
    Harper RG; Solish GI; Purow HM; Sang E; Panepinto WC
    Pediatrics; 1974 Sep; 54(3):300-5. PubMed ID: 4416175
    [No Abstract]   [Full Text] [Related]  

  • 23. [Behavioral features of the fetus, the neonate and the infant caused by maternal neurotropic drug ingestion. Feto-infantile pharmaco and iatrogenic etiopathology].
    Babin JP; Martin C
    Arch Fr Pediatr; 1986; 43(7):517-23. PubMed ID: 2879522
    [No Abstract]   [Full Text] [Related]  

  • 24. Fetal addiction to pentazocine.
    Kopelman AE
    Pediatrics; 1975 Jun; 55(6):888-9. PubMed ID: 1134890
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential effects of heroin and methadone on birth weights.
    Kandall SR; Albin S; Dreyer E; Comstock M; Lowinson J
    Addict Dis; 1975; 2(1-2):347-55. PubMed ID: 1163371
    [No Abstract]   [Full Text] [Related]  

  • 26. Environmental influences on embryonic and fetal development.
    McNall LK; Collea JV
    Curr Pract Obstet Gynecol Nurs; 1978; 2():67-90. PubMed ID: 255398
    [No Abstract]   [Full Text] [Related]  

  • 27. The transfer of drugs across the placenta.
    Long RF; Marks J
    Proc R Soc Med; 1969 Apr; 62(4):318-21. PubMed ID: 5811928
    [No Abstract]   [Full Text] [Related]  

  • 28. Disposition of methadone and its relationship to severity of withdrawal in the newborn.
    Rosen TS; Pippenger CE
    Addict Dis; 1975; 2(1-2):169-78. PubMed ID: 1163360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary problems encountered by the infant of the drug-dependent mother.
    Finnegan LP
    Clin Chest Med; 1980 Sep; 1(3):311-25. PubMed ID: 7028377
    [No Abstract]   [Full Text] [Related]  

  • 30. Fetal nutrition: how we become what we are.
    McClellan R; Novak D
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33(3):233-44. PubMed ID: 11593115
    [No Abstract]   [Full Text] [Related]  

  • 31. Narcotic withdrawal in the newborn infant.
    Glass L
    J Natl Med Assoc; 1974 Mar; 66(2):117-20. PubMed ID: 4819887
    [No Abstract]   [Full Text] [Related]  

  • 32. Drugs and pregnancy.
    Scott A
    J Ir Med Assoc; 1974 Mar; 67(5):123-6. PubMed ID: 4815646
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit.
    Krauer B; Krauer F; Hytten FE
    Pharmacol Ther; 1980; 10(2):301-28. PubMed ID: 7413726
    [No Abstract]   [Full Text] [Related]  

  • 34. Methadone assays in pregnant women and progeny.
    Blinick G; Inturrisi CE; Jerez E; Wallach RC
    Am J Obstet Gynecol; 1975 Mar; 121(5):617-21. PubMed ID: 1115163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological and behavioural effects of the transplacental transfer of narcotic drugs to the foetuses and neonates of narcotic-dependent mothers.
    Finnegan LP
    Bull Narc; 1979; 31(3-4):1-58. PubMed ID: 397848
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prenatal dystrophy].
    Manzke H
    Med Monatsschr; 1974 Jan; 28(1):14-9. PubMed ID: 4598912
    [No Abstract]   [Full Text] [Related]  

  • 37. The use and abuse of drugs in pregnancy.
    Cameron IT
    Br J Hosp Med; 1984 Oct; 32(4):182, 184, 186. PubMed ID: 6487878
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytogenetic risks to the offspring of pregnant addicts.
    Abrams CA
    Addict Dis; 1975; 2(1-2):63-77. PubMed ID: 1163374
    [No Abstract]   [Full Text] [Related]  

  • 39. Animal models for study of fetal drug exposure.
    Rudolph AM
    NIDA Res Monogr; 1985; 60():5-16. PubMed ID: 3932866
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications.
    DeVane CL
    NIDA Res Monogr; 1995; 149():116-29. PubMed ID: 8775838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.